Fundraising FoxElaia — 2023 Investments
7 investments dated 2023 · listed companies and verified rows first · show all
Gleamer develops AI copilot software for medical imaging that assists radiologists in detecting pathologies and generating diagnostic reports across X-ray, CT, and MRI modalities.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechMedical DevicesParis, FR
Christian Allouche(Founder)inAlexis Ducarouge(Founder)inDr Nor-Eddine Regnard(Founder)
Co-investorsXAngeBpifranceHeal CapitalKima VenturesPSL Innovation FundSupernova Invest+2 more
DJUST provides a B2B digital commerce platform that helps large companies build and run their B2B commerce operations.
AI & Machine LearningE-commerceEnterprise SoftwareSaaS
Alexis Delplanque(Founder)inArnaud Rihiant(Founder)inEric Gaudin(Founder)
Co-investorsNew Enterprise Associates (NEA)SpeedinvestNauta CapitalOpera Tech Ventures
AdTechAI & Machine Learning
Guillaume Grimbert(Founder)in
Co-investorsFamille C Participations
i-Virtual develops Saphere, a video-based vital sign measurement API that uses remote photoplethysmography (rPPG) and AI to extract health metrics like heart rate, respiratory rate, and stress levels from a 30-second selfie, serving wellness apps, insurtech platforms, and connected device makers.
AI & Machine LearningHealthtechSaaS
SESAMm provides big data, data science, and machine learning analytics to investment firms, supporting deal sourcing, due diligence, and portfolio value creation.
AI & Machine LearningData & InfrastructureFintech
Sylvain Forté(Founder)inFlorian Aubry(Founder)Pierre Rinaldi(Founder)
Co-investorsCameleon InvestOpera Tech VenturesAFG PartnersCarlyle GroupElevator Ventures
Tinyclues offers a predictive marketing platform that anticipates customer purchase intentions and orchestrates personalized campaigns across multiple channels and messaging services.
AI & Machine LearningMarketing TechSaaS
Co-investorsIsaiISAI GestionAlven CapitalEQT Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.